Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03103581 · ClinicalTrials.gov registry record · Phase 2
BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects
A Phase 2 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
NCT03103581 is a Phase 2 study that has completed, run by Braintree Laboratories. The registered enrollment target is 17 participants.
The verdict
NCT03103581, a Phase 2 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and efficacy of BLI4700 as a bowel preparation prior to colonoscopy in adult patients.
Interventions
- DRUG BLI4700
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2017-02-16 |
| Est. Completion | 2017-04-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03103581
The ClinicalTrials.gov registry entry for NCT03103581 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BLI4700 is the first listed.
NCT03103581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03103581 about?
NCT03103581 is a clinical study titled "BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects". The objective of this study is to evaluate the safety and efficacy of BLI4700 as a bowel preparation prior to colonoscopy in adult patients.
What is the current status of trial NCT03103581?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2017-02-16. Estimated completion is 2017-04-10.
What interventions are being tested in trial NCT03103581?
The interventions under investigation include: BLI4700 (DRUG).
Who is sponsoring clinical trial NCT03103581?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.